
Charles River Laboratories International (CRL) Assets
Market Cap: $5.65B
Avg Volume: 1.68M
Industry: Medical - Diagnostics & Research
Sector: Healthcare
Charles River Laboratories International Asset Metrics Summary
According to Charles River Laboratories International's latest annual financial reports, the company's asset profile is as follows:
Total Assets
Charles River Laboratories International's total assets amount to $7.53B. This is divided into:
- Total Current Assets: $1.40B
- Total Non-current Assets: $6.13B
- Net Receivables: $720.91M
- Inventory: $278.54M
- Cash and Short-term Investments: $194.61M
- Property, Plant, and Equipment (Net): $2.02B
- Long-term Investments: $218.35M
- Goodwill and Intangible Assets: $3.57B
Asset Ratios and Metrics
To better understand Charles River Laboratories International's asset management, we can look at several key ratios:
- Return on Assets (ROA): 0.29% - this indicates how profitable a company is relative to its total assets.
- Asset Turnover: 0.54 - this shows how efficiently a company uses its assets to generate sales.
- Current Ratio: 1.41 - this measures a company's ability to pay short-term obligations with its current assets.
- Quick Ratio: 1.13 - this indicates a company's ability to meet short-term obligations with its most liquid assets.
- Cash Ratio: 0.20 - this measures a company's ability to pay off short-term liabilities with its cash and cash equivalents.
These metrics provide insight into Charles River Laboratories International's asset efficiency and liquidity. For a comprehensive understanding of the company's financial health, it's important to consider these asset metrics alongside other financial indicators and industry benchmarks.
Total Assets
$7.53B
Total Current Assets
$1.40B
Total Non-current Assets
$6.13B
Net Receivables
$720.91M
Inventory
$278.54M
Cash and Short-term Investments
$194.61M
Property, Plant, and Equipment (Net)
$2.02B
Long-term Investments
$218.35M
Goodwill and Intangible Assets
$3.57B
Return on Assets
0.29%
Asset Turnover
0.54
Current Ratio
1.41
Charles River Laboratories International Historical Asset Metrics
Historical Return on Assets
Historical Total Assets Growth
Charles River Laboratories International Historical Assets
The table below shows various asset metrics for each year, with the latest data available for the last fiscal year 2024.
Year | Total Assets | Total Current Assets | Total Non-current Assets | Net Receivables | Inventory | Cash and Short-term Investments | Property, Plant, Equipment (Net) | Long-term Investments | Goodwill and Intangible Assets | Return on Assets | Asset Turnover | Current Ratio | Quick Ratio | Cash Ratio |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | $7.53B | $1.40B | $6.13B | $720.91M | $278.54M | $194.61M | $2.02B | $218.35M | $3.57B | 0.00 | 0.54 | 1.41 | 1.13 | 0.20 |
2023 | $8.20B | $1.61B | $6.59B | $780.38M | $380.26M | $276.77M | $2.03B | $243.81M | $3.96B | 0.06 | 0.50 | 1.52 | 1.16 | 0.26 |
2022 | $7.60B | $1.44B | $6.16B | $752.39M | $255.81M | $233.91M | $1.86B | $311.60M | $3.81B | 0.06 | 0.52 | 1.32 | 1.08 | 0.21 |
2021 | $7.02B | $1.27B | $5.75B | $642.88M | $199.15M | $241.21M | $1.58B | $201.35M | $3.77B | 0.06 | 0.50 | 1.23 | 1.04 | 0.23 |
2020 | $5.49B | $1.20B | $4.29B | $617.74M | $185.69M | $228.42M | $1.30B | $221.80M | $2.60B | 0.07 | 0.53 | 1.43 | 1.21 | 0.27 |
2019 | $4.69B | $1.02B | $3.67B | $514.03M | $160.66M | $238.01M | $1.18B | $122.98M | $2.23B | 0.05 | 0.56 | 1.44 | 1.21 | 0.34 |
2018 | $3.86B | $897.84M | $2.96B | $472.25M | $127.89M | $195.44M | $932.88M | $88.59M | $1.86B | 0.06 | 0.59 | 1.61 | 1.38 | 0.35 |
2017 | $2.93B | $826.62M | $2.10B | $430.02M | $114.96M | $163.79M | $781.97M | $71.10M | $1.17B | 0.04 | 0.63 | 1.78 | 1.54 | 0.35 |
2016 | $2.71B | $656.83M | $2.05B | $364.05M | $95.83M | $117.63M | $755.83M | $45.33M | $1.18B | 0.06 | 0.62 | 1.53 | 1.31 | 0.27 |
2015 | $2.07B | $559.23M | $1.51B | $270.07M | $93.73M | $117.95M | $677.96M | $32.73M | $719.63M | 0.07 | 0.66 | 1.79 | 1.49 | 0.38 |
Related Metrics
Explore detailed financial metrics and analysis for CRL.